Investor Class Actions
Securities Fraud Class Actions Filed Against Three Companies by Investors
Anonymous
Key Points
1
The Wix class period is alleged to run from February 19, 2025, through May 12, 2026, and investors may seek recovery even if they still hold their shares; participation involves no cost or obligation.
2
The Park Ha case covers investors who acquired the company’s securities from December 27, 2024, through July 8, 2025, as well as investors whose purchases were connected to Park Ha’s December 27, 2024, IPO.
3
Aardvark investors who bought stock in or traceable to the company’s February 13, 2025, IPO, or who purchased securities through May 14, 2026, are included in the proposed class period; Hagens Berman urged investors to contact the firm before the October 13, 2026, lead-plaintiff deadline.
4
The Aardvark complaint specifically alleges that the company’s offering documents failed to provide information required by law, in addition to allegedly misstating ARD-101’s safety and prospects.
Three companies now face securities class actions over alleged investor deception. Faruqi & Faruqi is pursuing claims against Wix.com for overstating its AI product benefits while hiding true costs. Separate lawsuits target Park Ha Biological Technology for stock manipulation and fake social-media promotion, and Aardvark Therapeutics for exaggerating its ARD-101 drug's safety and commercial potential. None of these allegations have been proven in court.
Investors who bought shares during specific periods — or during the companies' IPOs — can join the lawsuits at no cost or risk. The cases offer a chance to recover losses without paying upfront fees. Law firms are now actively recruiting lead plaintiffs to represent the broader investor groups in each action.
Wix Accused of Hiding Real AI Development Costs
Faruqi & Faruqi claims Wix.com misled investors about its artificial-intelligence products from February 19, 2025, through May 12, 2026. The complaint alleges the company exaggerated how competitive and profitable its AI tools were. At the same time, prosecutors say Wix hid the true cost of building and promoting those products. Investors can seek damages even if they still own Wix shares today.
The deadline to become the lead plaintiff in this case is September 22, 2026. Joining the class requires no money upfront and no obligation to stay involved. Faruqi & Faruqi is asking all affected shareholders to contact the firm about their claim.
Park Ha's Stock Scheme Used Fake Experts and Hype
Park Ha Biological Technology faces accusations of orchestrating a stock-manipulation scheme that relied on social-media lies and impersonated financial professionals. The company went public on December 27, 2024, with an unusually small number of tradeable shares — a red flag for potential pump-and-dump fraud. The class action covers anyone who bought Park Ha stock from December 27, 2024, through July 8, 2025, including IPO-period purchases.
Manipulating stock prices through false social-media posts and fake expert endorsements is a direct violation of securities law. Investors harmed by Park Ha's alleged scheme can file a claim without paying any fees upfront. Law firms are recruiting lead plaintiffs to represent the larger investor group.
Aardvark Overstated Safety of ARD-101 Drug, Lawsuit Says
Aardvark Therapeutics is accused of exaggerating the safety and commercial promise of its ARD-101 treatment. The company's IPO documents on February 13, 2025, allegedly left out required information and made false claims about the drug's prospects. Hagens Berman warns that investors who bought shares during the IPO or anytime through May 14, 2026, may have a claim. The lead-plaintiff deadline is October 13, 2026.
Drug companies that overstate safety data or clinical results put investors at serious financial risk. When a promising treatment fails trials or faces regulatory setbacks, stock prices often collapse. Aardvark investors who suffered losses can contact Hagens Berman to discuss their potential recovery without upfront costs.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
35
Articles
111
Reach
146
A
AnonymousAuthor
